The role of substrate topography on the cellular uptake of nanoparticles

Improving targeting efficacy has been a central focus of the studies on nanoparticle (NP)-based drug delivery nanocarriers over the past decades. As cells actively sense and respond to the local physical environments, not only the NP design (e.g., size, shape, ligand density, etc.) but also the cell...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomedical materials research. Part B, Applied biomaterials Vol. 104; no. 3; pp. 488 - 495
Main Authors Huang, Changjin, Ozdemir, Tugba, Xu, Li-Chong, Butler, Peter J., Siedlecki, Christopher A., Brown, Justin L., Zhang, Sulin
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.04.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Improving targeting efficacy has been a central focus of the studies on nanoparticle (NP)-based drug delivery nanocarriers over the past decades. As cells actively sense and respond to the local physical environments, not only the NP design (e.g., size, shape, ligand density, etc.) but also the cell mechanics (e.g., stiffness, spreading, expressed receptors, etc.) affect the cellular uptake efficiency. While much work has been done to elucidate the roles of NP design for cells seeded on a flat tissue culture surface, how the local physical environments of cells mediate uptake of NPs remains unexplored, despite the widely known effect of local physical environments on cellular responses in vitro and disease states in vivo. Here, we report the active responses of human osteosarcoma cells to fibrous substrate topographies and the subsequent changes in the cellular uptake of NPs. Our experiments demonstrate that surface topography modulates cellular uptake efficacy by mediating cell spreading and membrane mechanics. The findings provide a concrete example of the regulative role of the physical environments of cells on cellular uptake of NPs, therefore advancing the rational design of NPs for enhanced drug delivery in targeted cancer therapy.
Bibliography:National Science Foundation - No. CMMI 13-34847
ArticleID:JBMB33397
ark:/67375/WNG-BQGLVQ9R-H
National Institutes of Health - No. R21EB019230
istex:C358B961F5ADEC263B07B47B0ED7CAFA546DF95C
National Science Foundation - No. CMMI-0754463; CBET-1067523
National Institutes of Health - No. R21HL122902
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Both authors contributed equally to this work.
ISSN:1552-4973
1552-4981
DOI:10.1002/jbm.b.33397